{"log_id": 5227916653438992087, "direction": 0, "words_result_num": 45, "words_result": [{"probability": {"variance": 5e-06, "average": 0.99812, "min": 0.993093}, "location": {"width": 297, "top": 148, "height": 31, "left": 185}, "words": "核准日期:2007年07月03日"}, {"probability": {"variance": 0.023108, "average": 0.913749, "min": 0.502313}, "location": {"width": 508, "top": 183, "height": 44, "left": 186}, "words": "修改日期:2008年03小电药品管理"}, {"probability": {"variance": 0.025897, "average": 0.874065, "min": 0.451577}, "location": {"width": 243, "top": 232, "height": 35, "left": 299}, "words": "2008年13月15"}, {"probability": {"variance": 1.7e-05, "average": 0.997348, "min": 0.988186}, "location": {"width": 357, "top": 312, "height": 52, "left": 451}, "words": "注射用尿激酶说明书"}, {"probability": {"variance": 0, "average": 0.999347, "min": 0.997607}, "location": {"width": 571, "top": 391, "height": 46, "left": 326}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0, "average": 0.999313, "min": 0.998274}, "location": {"width": 125, "top": 456, "height": 26, "left": 198}, "words": "【药品名称】"}, {"probability": {"variance": 0.001033, "average": 0.986478, "min": 0.886941}, "location": {"width": 231, "top": 485, "height": 27, "left": 235}, "words": "通用名称:注射用尿激酶"}, {"probability": {"variance": 0.006296, "average": 0.964552, "min": 0.754914}, "location": {"width": 241, "top": 520, "height": 25, "left": 236}, "words": "英文名称: Urokinase for In"}, {"probability": {"variance": 1.7e-05, "average": 0.99648, "min": 0.988195}, "location": {"width": 232, "top": 552, "height": 25, "left": 235}, "words": "汉语拼音 Zhusheyong N"}, {"probability": {"variance": 0, "average": 0.99798, "min": 0.997347}, "location": {"width": 78, "top": 584, "height": 25, "left": 200}, "words": "【成份】"}, {"probability": {"variance": 0.001116, "average": 0.99265, "min": 0.790019}, "location": {"width": 818, "top": 605, "height": 39, "left": 249}, "words": "本品主要成份及其化学名称为:从健康人尿中分离的,或从人肾组织培养中获得的一种"}, {"probability": {"variance": 0.01857, "average": 0.906478, "min": 0.377024}, "location": {"width": 876, "top": 639, "height": 40, "left": 193}, "words": "酶蛋白。由分子量分别为33000MW-tCu-PA)和54000HMW-tCu-PA)两部分组成。每毫克蛋"}, {"probability": {"variance": 0.000427, "average": 0.989652, "min": 0.923252}, "location": {"width": 569, "top": 675, "height": 36, "left": 194}, "words": "白中尿激酶活力不得少于12万单位。辅料为:人血白蛋白"}, {"probability": {"variance": 0, "average": 0.999005, "min": 0.998687}, "location": {"width": 82, "top": 716, "height": 26, "left": 198}, "words": "性状】"}, {"probability": {"variance": 0.009682, "average": 0.967039, "min": 0.57069}, "location": {"width": 404, "top": 742, "height": 33, "left": 238}, "words": "本品为白色或类白色的东干块状物或粉末"}, {"probability": {"variance": 7.7e-05, "average": 0.994664, "min": 0.977303}, "location": {"width": 96, "top": 780, "height": 25, "left": 202}, "words": "【适应症】"}, {"probability": {"variance": 0.01706, "average": 0.960134, "min": 0.376096}, "location": {"width": 519, "top": 805, "height": 37, "left": 239}, "words": "本品主要用于血栓栓塞性疾病的溶栓治疗。急性"}, {"probability": {"variance": 0.008015, "average": 0.95996, "min": 0.69705}, "location": {"width": 211, "top": 806, "height": 26, "left": 858}, "words": "塞、胸痛6~12小时内"}, {"probability": {"variance": 0.010893, "average": 0.957786, "min": 0.58882}, "location": {"width": 876, "top": 834, "height": 45, "left": 195}, "words": "的冠状动脉栓塞和心肌梗症状短3~6小时的急期脑血管栓膜动脉栓塞和其"}, {"probability": {"variance": 6.3e-05, "average": 0.995848, "min": 0.968452}, "location": {"width": 534, "top": 861, "height": 48, "left": 195}, "words": "他外周动脉栓塞症状严重的骼静脉血栓形成者"}, {"probability": {"variance": 0, "average": 0.706493, "min": 0.706493}, "location": {"width": 136, "top": 864, "height": 41, "left": 716}, "words": "用"}, {"probability": {"variance": 0.006823, "average": 0.958112, "min": 0.750526}, "location": {"width": 201, "top": 866, "height": 33, "left": 823}, "words": "瓣手术后预防血栓形"}, {"probability": {"variance": 0.008905, "average": 0.972108, "min": 0.536432}, "location": {"width": 604, "top": 882, "height": 64, "left": 194}, "words": "保持血管插管和胸腔及心包腔引流管的通畅等。溶栓的"}, {"probability": {"variance": 0.000396, "average": 0.987629, "min": 0.934352}, "location": {"width": 220, "top": 904, "height": 28, "left": 837}, "words": "继的肝素抗凝加以维持"}, {"probability": {"variance": 1e-06, "average": 0.998877, "min": 0.997724}, "location": {"width": 79, "top": 944, "height": 28, "left": 202}, "words": "【规格】"}, {"probability": {"variance": 0.008954, "average": 0.94366, "min": 0.697764}, "location": {"width": 830, "top": 968, "height": 42, "left": 242}, "words": "(1万单位(2)2万单位(3)5万单位(410万单位(5)20万单位(6)25万单"}, {"probability": {"variance": 0.000708, "average": 0.981786, "min": 0.878726}, "location": {"width": 474, "top": 1005, "height": 36, "left": 197}, "words": "位(7)50万单位(8)100万单位(9150万单位"}, {"probability": {"variance": 6e-05, "average": 0.993001, "min": 0.976694}, "location": {"width": 124, "top": 1044, "height": 26, "left": 204}, "words": "【用法用量】"}, {"probability": {"variance": 2.1e-05, "average": 0.997284, "min": 0.978784}, "location": {"width": 570, "top": 1069, "height": 34, "left": 241}, "words": "本品临用前应以注射用灭菌生理盐水或5%葡萄糖溶液配制"}, {"probability": {"variance": 0, "average": 0.981645, "min": 0.981645}, "location": {"width": 158, "top": 1025, "height": 66, "left": 899}, "words": "世"}, {"probability": {"variance": 0.00938, "average": 0.960946, "min": 0.512594}, "location": {"width": 818, "top": 1099, "height": 36, "left": 257}, "words": "肺栓塞初次剂量按体重400单位/公斤,以0.9%氯化钠溶液或5%葡萄糖溶液配制"}, {"probability": {"variance": 0.003112, "average": 0.989425, "min": 0.62861}, "location": {"width": 873, "top": 1131, "height": 38, "left": 198}, "words": "以90毫升/小时速度在10分钟内滴完;其后以每小时4400单位的给药速度,连续静脉滴注"}, {"probability": {"variance": 0.004838, "average": 0.975136, "min": 0.637397}, "location": {"width": 873, "top": 1163, "height": 39, "left": 196}, "words": "2小时或12小时。肺栓塞时,也可按每公斤体重15000单位用0.9%氯化钠溶液配制后肺动"}, {"probability": {"variance": 0.006021, "average": 0.983136, "min": 0.536586}, "location": {"width": 787, "top": 1198, "height": 38, "left": 197}, "words": "脉内注入;必要时,可根据情况调整剂量,间隔24小时重复一次,最多使用三次"}, {"probability": {"variance": 0.009624, "average": 0.970558, "min": 0.526162}, "location": {"width": 830, "top": 1231, "height": 38, "left": 242}, "words": "2.心肌梗死建议以0.9%氯化钠溶液配制后,按6000单位分速度冠状动脉内连续滴注"}, {"probability": {"variance": 0.011019, "average": 0.968886, "min": 0.36189}, "location": {"width": 881, "top": 1262, "height": 40, "left": 196}, "words": "2小时,滴注前应先行静脉给予肝素250010000单位。也可将本品200万~300万单位配制"}, {"probability": {"variance": 0.002898, "average": 0.981157, "min": 0.776668}, "location": {"width": 352, "top": 1303, "height": 31, "left": 200}, "words": "后静脉滴注,45分钟到90分钟滴完"}, {"probability": {"variance": 0.002063, "average": 0.981804, "min": 0.752397}, "location": {"width": 832, "top": 1329, "height": 38, "left": 243}, "words": "3外周动脉血栓以0.9%氯化钠溶液配制本品(浓度2500单位/毫升)4000单位/分速"}, {"probability": {"variance": 0.001759, "average": 0.986369, "min": 0.778906}, "location": {"width": 877, "top": 1364, "height": 36, "left": 199}, "words": "度经导管注入血凝块。每2小时夹闭导管1次;可调整滴入速度为1000单位/分,直至血块"}, {"probability": {"variance": 0, "average": 0.999463, "min": 0.999126}, "location": {"width": 49, "top": 1407, "height": 26, "left": 198}, "words": "溶解"}, {"probability": {"variance": 6e-06, "average": 0.998069, "min": 0.987144}, "location": {"width": 813, "top": 1428, "height": 39, "left": 243}, "words": "4防治心脏瓣膜替换术后的血栓形成血栓形成是心脏瓣膜术后最常见的并发症之一"}, {"probability": {"variance": 0.005789, "average": 0.983089, "min": 0.482001}, "location": {"width": 877, "top": 1462, "height": 39, "left": 200}, "words": "可用本品按体重4400单位/公斤,0.9%氯化钠溶液配制后10分钟到15分钟滴完。然后以每"}, {"probability": {"variance": 0.003009, "average": 0.987407, "min": 0.637957}, "location": {"width": 878, "top": 1496, "height": 40, "left": 200}, "words": "小时按体重4400单位/公斤的速度静脉滴注维持。当瓣膜功能正常后即停止用药;如用药24"}, {"probability": {"variance": 4e-06, "average": 0.99857, "min": 0.992014}, "location": {"width": 381, "top": 1536, "height": 29, "left": 200}, "words": "小时仍无效或发生严重出血倾向应停药"}, {"probability": {"variance": 8.1e-05, "average": 0.995571, "min": 0.957428}, "location": {"width": 832, "top": 1563, "height": 38, "left": 243}, "words": "5脓胸或心包积脓常用抗生素和脓液引流术治疗。引流管常因纤维蛋白形成凝块而阻"}], "language": 3}